Search

You searched for "noninvasive"

217 results found

Changing trends in the management of osteoradionecrosis (ORN)

5 August 2014 | | PMFA - Maxillofacial Surgery
In the wake of new drugs that have been introduced for ORN like pentoxifylline, tocopherol, clodronate etc, traditional ‘conservative’ management of osteoradionecrosis (ORN) including minimal surgical debridement and hyperbaric oxygen therapy (HBOT) is under review. This study is a retrospective...

Thread lifting – the fundamentals

1 September 2022 | | PMFA - Aesthetic Medicine
"Thread lifting” is a minimally invasive outpatient procedure that is becoming increasingly popular internationally [1-3]. Threads are surgical sutures that can be utilised for facial and body contouring and rejuvenation. These sutures can be used for skin rejuvenation as bio-stimulators...

What’s new on the horizon for toxins coming to the market?

1 February 2019 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
With the ever increasing demand for injectable treatments, it is important to keep abreast of new developments in the field. International expert Michael Gold reviews the new toxins due to be hitting the market in the next year. We are...

Management of masseter hypertrophy and bruxism with Botulinum Toxin A

3 August 2021 | | PMFA - CPD, PMFA - Aesthetic Medicine, PMFA - Facial Plastic Surgery, PMFA - Maxillofacial Surgery
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. The squaring of the lower third of the face can be an...

IMCAS China 2015

2 July 2015 |
The IMCAS brand is now well established as a global leader in bringing together a multi-disciplinary, multi-professional approach to the world of ‘aesthetic surgery and cosmetic dermatology’. The first meeting was held in Paris in 1994 and was promoted as...

Gross Negligence Manslaughter in Healthcare: The medico-legal dilemma (part 18) - The judge fails at maths

14 March 2022 |
I was troubled by the Judge's response and wondered what a mathematician would have thought of it. So, the following emails ensued:

Sinclair presents Sculpt&Shape® at IMCAS Paris 2023

1 February 2023 | Research & Development, Awards, Conferences & Anniversaries
Sinclair, formally Sinclair Pharma (“Sinclair”, www.sinclair.com) a global aesthetics company headquartered in London and fully owned subsidiary of Huadong Medicine Corporation Limited presents Sculpt&Shape® at the IMCAS 2023 congress in Paris.

The golden nose – reshaping the nose 100 years ago

30 May 2023 | | PMFA - Aesthetic Medicine
Wolf Lűbbers (with the golden nose). Who with a crooked nose would not embrace the chance to go to bed in the evening wearing a surgical device and wake up the following morning with a straight one? And all this...

Do You Know Your Advertising Standards?

1 February 2014 | | PMFA - Aesthetic Medicine
Over the last couple of years we have seen many organisations, including the British Association of Aesthetic Plastic Surgeons (BAAPS) seek to ban or at least rein in some of the advertising practices which go on in this industry [1]....

How I Do It - Utilising ARES AK and AO as a multi-factorial approach

3 October 2024 | | PMFA - Dermatology, PMFA - Aesthetic Medicine
The Advanced Regenerative Esthetic Solutions (ARES®) line from CMed Aesthetics positions itself as “the most innovative mesotherapy line”. Mesotherapy is a minimally invasive cosmetic treatment that involves injecting small amounts of vitamins, enzymes, hormones, and other substances into the middle...

The AMWC 2023 awards - WINNERS

1 April 2023 | PMFA - Aesthetic Medicine, PMFA - Dermatology
In partnership with the Aesthetic Multispecialty Society (AMS), the 2023 AMWC Awards honour physicians for their innovative protocols and techniques, in addition to treatment results in the field of aesthetic & anti-ageing medicine. The winners were announced this weekend at...

PhilArt is now PolyPhil™: NEW NAME, SAME TRUSTED QUALITY

12 March 2025 | Research & Development
CROMA-PHARMA®, a global leader in minimally-invasive aesthetic medicine, is excited to announce that its range of injectable polynucleotides “PhilArt” is rebranding to better reflect the products’ exceptional attributes and to position them for global market expansion. PolyPhil™ succeeds the well-established...